200 related articles for article (PubMed ID: 12227896)
41. [Progestins and the endometrium].
Schindler AE
Zentralbl Gynakol; 1997; 119 Suppl 2():59-63. PubMed ID: 9441543
[TBL] [Abstract][Full Text] [Related]
42. Hormone replacement and cancer.
Barrett-Connor E
Br Med Bull; 1992 Apr; 48(2):345-55. PubMed ID: 1450874
[TBL] [Abstract][Full Text] [Related]
43. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Ross RK; Paganini-Hill A; Wan PC; Pike MC
J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
[TBL] [Abstract][Full Text] [Related]
44. [The present state of research on the relationship of oral contraceptives to breast cancer].
Pike MC
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
[TBL] [Abstract][Full Text] [Related]
45. Progestins in the menopause.
Sitruk-Ware R
J Steroid Biochem Mol Biol; 1999; 69(1-6):185-93. PubMed ID: 10418992
[TBL] [Abstract][Full Text] [Related]
46. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
47. Progestins and breast cancer: an epidemiologic review.
Staffa JA; Newschaffer CJ; Jones JK; Miller V
Fertil Steril; 1992 Mar; 57(3):473-91. PubMed ID: 1740192
[TBL] [Abstract][Full Text] [Related]
48. [Estrogens, progestins and cancer of the endometrium].
Laffargue F; Daures JP
Rev Prat; 1993 Dec; 43(20):2603-9. PubMed ID: 8146558
[TBL] [Abstract][Full Text] [Related]
49. Postmenopausal hormone replacement therapy--clinical implications.
Ravn SH; Rosenberg J; Bostofte E
Eur J Obstet Gynecol Reprod Biol; 1994 Feb; 53(2):81-93. PubMed ID: 8194655
[TBL] [Abstract][Full Text] [Related]
50. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.
Pike MC; Spicer DV; Dahmoush L; Press MF
Epidemiol Rev; 1993; 15(1):17-35. PubMed ID: 8405201
[TBL] [Abstract][Full Text] [Related]
51. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
52. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
[TBL] [Abstract][Full Text] [Related]
53. Hormone replacement therapy and estrogen-dependent cancers.
Birkhäuser M
Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():99-114. PubMed ID: 7874193
[TBL] [Abstract][Full Text] [Related]
54. The benefits and risks of hormone replacement therapy: an epidemiologic overview.
Harlap S
Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1986-92. PubMed ID: 1605289
[TBL] [Abstract][Full Text] [Related]
55. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
56. Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells.
Botella J; Duranti E; Viader V; Duc I; Delansorne R; Paris J
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):77-84. PubMed ID: 7577723
[TBL] [Abstract][Full Text] [Related]
57. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
58. New progestogens: a review of their effects in perimenopausal and postmenopausal women.
Sitruk-Ware R
Drugs Aging; 2004; 21(13):865-83. PubMed ID: 15493951
[TBL] [Abstract][Full Text] [Related]
59. Progestins and breast cancer.
Pasqualini JR; Paris J; Sitruk-Ware R; Chetrite G; Botella J
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):225-35. PubMed ID: 9699877
[TBL] [Abstract][Full Text] [Related]
60. Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis.
Horwitz KB; Sartorius CA
J Clin Endocrinol Metab; 2008 Sep; 93(9):3295-8. PubMed ID: 18647813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
